Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents

Preface
pp. i-iI(2)
Authors: R. Emmerling M.; E. Roher A.

Modulation of Alzheimer's Amyloidosis by Statins: Mechanisms of Action
pp. 1-7(7)
Authors: Petanceska S.; Pappolla M.; Refolo L.M.

The Medicinal Metallochemistry of Alzheimer's Disease
pp. 9-13(5)
Authors: Cherny R.A.; Masters C.L.; Bush A.I.

A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimer's Disease
pp. 15-25(11)
Authors: Cole G.M.; Yang F.; Lim G.P.; Cummings J.L.; Masterman D.L.; Frautschy S.A.

The Association of Microglial Activation and Amyloid Reduction in APP+PS1 Transgenic Mice
pp. 27-32(6)
Authors: Morgan D.; Jantzen P.; Wilcock D.; DiCarlo G.; Ugen K.; Gordon M.

Oxidative Mediated Neurodegeneration in Alzheimer's Disease: Melatonin and Related Indoles as Neuroprotective Agents
pp. 33-46(14)
Authors: Pappolla M.A.; Reiter R.J.; Bryant-Thomas T.K.; Poeggeler B.

BACE1 Deficient Mice: Their Role in Drug Target Validation and Implications for Alzheimer's Disease Therapies
pp. 47-55(9)
Author: Vassar R.

Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes A Deposition: Towards a Physiologic Animal Model of Alzheimer's Disease
pp. 57-75(19)
Authors: Beach T.G.; Walker D.G.; Sue L.I.; Scott S.; Layne K.J.; Newell A.J.; Potter P.E.; Durham R.A.; Emmerling M.R.; Webster S.D.

Autonomic Sudomotor Dysfunction in Alzheimer's Disease
pp. 77-84(8)
Authors: Smith R.Glenn; Roher A.E.; Appel S.H.; Doody R.S.; Killian J.M.; Corey-Bloom J.; Sabbagh M.N.

Appraisal of APP Transgenic Mice as Models for Alzheimer's Disease Amyloid Cascade
pp. 85-90(6)
Authors: Roher A.E.; Kokjohn T.A.

Author Index To Volume 2
pp. 91-91(1)
Author: Bentham S.Publishers

subject Index To Volume 2
pp. 93-94(2)
Author: Bentham S.Publishers